Drugs / GCSF (granulocyte colony stimulating factor)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT00068393 Background | Feb 2004 → Jun 2009 | sarcomatoid renal cell carcinoma | Eastern Cooperative Oncology Group | Completed | No outcome recorded |
| Phase 2 | NCT00006184 Background | Feb 2001 → Jan 2008 | plasma cell myeloma | National Cancer Institute (NCI) | Completed | No outcome recorded |
| Phase 2 | NCT00483067 Background | Mar 1998 → Mar 2006 | leukemia | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCSF (granulocyte colony stimulating factor) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006184 ↗ |
| Route | Subcutaneous | “10 mcg/kg per day subcutaneously daily from day 5” NCT00006184 ↗ |